- Home
- VANI vs LOAN Comparison
VANI vs LOAN Comparison
Compare VANI & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- LOAN
- Stock Information
- Founded
- VANI 1998
- LOAN 1989
- Country
- VANI United States
- LOAN United States
- Employees
- VANI N/A
- LOAN N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LOAN Real Estate Investment Trusts
- Sector
- VANI Health Care
- LOAN Real Estate
- Exchange
- VANI Nasdaq
- LOAN Nasdaq
- Market Cap
- VANI 68.1M
- LOAN 58.1M
- IPO Year
- VANI 2014
- LOAN 1999
- Fundamental
- Price
- VANI $1.15
- LOAN $5.20
- Analyst Decision
- VANI Strong Buy
- LOAN
- Analyst Count
- VANI 1
- LOAN 0
- Target Price
- VANI $4.00
- LOAN N/A
- AVG Volume (30 Days)
- VANI 136.2K
- LOAN 13.6K
- Earning Date
- VANI 08-12-2025
- LOAN 07-21-2025
- Dividend Yield
- VANI N/A
- LOAN 8.79%
- EPS Growth
- VANI N/A
- LOAN N/A
- EPS
- VANI N/A
- LOAN 0.48
- Revenue
- VANI N/A
- LOAN $7,291,468.00
- Revenue This Year
- VANI N/A
- LOAN N/A
- Revenue Next Year
- VANI N/A
- LOAN $4.41
- P/E Ratio
- VANI N/A
- LOAN $10.90
- Revenue Growth
- VANI N/A
- LOAN N/A
- 52 Week Low
- VANI $0.91
- LOAN $4.74
- 52 Week High
- VANI $1.50
- LOAN $6.05
- Technical
- Relative Strength Index (RSI)
- VANI 54.56
- LOAN 50.76
- Support Level
- VANI $1.13
- LOAN $5.13
- Resistance Level
- VANI $1.25
- LOAN $5.20
- Average True Range (ATR)
- VANI 0.05
- LOAN 0.10
- MACD
- VANI -0.01
- LOAN 0.01
- Stochastic Oscillator
- VANI 29.05
- LOAN 47.93
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.